Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 132 | 127 | −5 |
| Shares | 31.8M | 31.8M | −16.9K (−0.1%) |
| Value | $339.6M | $447.7M | +$108.1M (+31.8%) |
New holders (18)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fairmount Funds Management LLC | 704,459 | $9.92M | 1.40% |
| Soleus Capital Management, L.P. | 519,640 | $7.32M | 0.81% |
| GMT Capital Corp | 299,244 | $4.21M | 0.16% |
| Woodline Partners LP | 290,001 | $4.08M | 0.05% |
| Linden Thomas Advisory Services, LLC | 57,949 | $815.9K | 0.18% |
| Alps Advisors Inc | 51,394 | $723.6K | 0.01% |
| Cubist Systematic Strategies, LLC | 40,294 | $567.3K | 0.01% |
| Franklin Resources Inc | 29,104 | $409.8K | 0.00% |
| Jane Street Group, LLC | 26,419 | $372.0K | 0.00% |
| Point72 Middle East FZE | 25,669 | $361.4K | 0.02% |
| American Century Companies Inc | 11,205 | $157.8K | 0.00% |
| Cornerstone Investment Partners, LLC | 10,474 | $147.5K | 0.01% |
| Metropolitan Life Insurance Co | 1,846 | $26.0K | 0.00% |
| Cary Street Partner Investment Advisory LLC | 1,000 | $14.1K | 0.00% |
| Covestor Ltd | 160 | $2.00K | 0.00% |
| 25 LLC | 36 | $501 | 0.00% |
| Allworth Financial LP | 23 | $324 | 0.00% |
| Toronto Dominion Bank | 4 | $0 | 0.00% |
Sold out (23)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q1 2023 and filed for Q2 2023 without it.